TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6330643

Group type: EXPERIMENTAL
Intervention: Naloxone (0.8 mg in 2 ml vehicle each)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (2 ml)
Number of subjects: 12
Study: 30539266

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine 300 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29194531

Group type: EXPERIMENTAL
Intervention: Conservative surgery (shaving or disc excision)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Radical rectal surgery (segmental resection)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative surgery and Radical rectal surgery
Number of subjects: 60
Study: 25934317

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 24136379

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg intravenously 2 to 3 hours prior to surgery (Group A)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 108
Study: 22738085

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.42 (Tetraspan)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 798
Study: 20855843

Group type: EXPERIMENTAL
Intervention: PCV
Number of subjects: 447

Group type: COMPARATOR
Intervention: TMZ-5 (200 mg/m2 for 5 days)
Number of subjects: 447

Group type: COMPARATOR
Intervention: TMZ-21 (100 mg/m2 for 21 days)
Number of subjects: 447

Group type: COMPARATOR
Intervention: TMZ-5
Number of subjects: 447
Study: 18276076

Group type: EXPERIMENTAL
Intervention: Painful stimuli
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Non-painful stimuli
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (non-painful stimuli)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pain thresholds
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Attentional bias to stimuli
Number of subjects: 14
Study: 15680454

Group type: EXPERIMENTAL
Intervention: New cell-cultured smallpox vaccine (CCSV)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Calf-lymph derived vaccine (control)
Number of subjects: 350
Study: 12846615

Group type: EXPERIMENTAL
Intervention: Low-dose bupivacaine 4 mg with 25 micro g of fentanyl
Number of subjects: 2

Group type: COMPARATOR
Intervention: 0.5% plain bupivacaine 7.5 mg
Number of subjects: 2
Study: 10665784

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment in 10 fractions (total dose of 45 Gy)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment in 28 fractions
Number of subjects: 335

Group type: COMPARATOR
Intervention: Air treatment in 10 fractions (total dose of 40 Gy)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Air treatment in 28 fractions
Number of subjects: 335
Study: 8887208

Group type: EXPERIMENTAL
Intervention: Maximal isokinetic eccentric exercise (100 maximal eccentric activations of the knee extensors at 0.52 rad s‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Downhill run (5 bouts of 8 min at -10% gradient at 80% predicted maximal heart rate) without prior isokinetic session
Number of subjects: 10
Study: 1796125

Group type: EXPERIMENTAL
Intervention: 10 mg N-desmethyladinazolam
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 mg N-desmethyladinazolam
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 mg N-desmethyladinazolam
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: N-desmethyladinazolam (all doses)
Number of subjects: 15
Study: 6366027

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with a mixture of three grass pollen-aqueous extracts (velvet, sweet vernal, and timothy)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31677701

Group type: EXPERIMENTAL
Intervention: Prolonged elemental diet (ED) therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 39
Study: 29343173

Group type: EXPERIMENTAL
Intervention: Generic feedback with mean End-of-Life in Dementia-scores
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Patient-specific feedback with individual End-of-Life in Dementia-scores
Number of subjects: 668

Group type: COMPARATOR
Intervention: No feedback provided
Number of subjects: 668
Study: 26772739

Group type: EXPERIMENTAL
Intervention: Custom made insoles by a podiatrist
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo insoles
Number of subjects: 185

Group type: COMPARATOR
Intervention: Usual care by the general practitioner or sports physician
Number of subjects: 185
Study: 24533512

Group type: EXPERIMENTAL
Intervention: Social skills treatment based on Cognitive Behaviour Therapy principles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study: 22990651

Group type: EXPERIMENTAL
Intervention: Quartiles of vitamin D binding protein (DBP)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 25-hydroxyvitamin D (25(OH)D) quartiles
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 25(OH)D quartiles stratified by DBP (median split)
Number of subjects: 250
Study: 20660552

Group type: EXPERIMENTAL
Intervention: RUSFs (ready‐to‐use supplementary foods)
Number of subjects: 1645

Group type: COMPARATOR
Intervention: RUTFs (ready‐to‐use therapeutic foods)
Number of subjects: 1645
Study: 16956743

Group type: EXPERIMENTAL
Intervention: Structured 6-week neuropsychological course
Number of subjects: 69

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 69
Study: 17608739

Group type: EXPERIMENTAL
Intervention: BioOss (N=10; BG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BioOss and resorbable collagen membrane (N=10; BG+M)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No graft (N=10; control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Buccally positioned implants
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lingually positioned implants
Number of subjects: 30
Study: 15215086

Group type: EXPERIMENTAL
Intervention: 12 mg/kg every 12 h for 3 doses and then 15 mg/kg every 48 h for 4 doses (daily dosing)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 6 mg/kg every 12 h for 2 doses and then 6 mg/kg every 24 h for 9 doses (alternate-day dosing)
Number of subjects: 24
Study: 11408300

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention
Number of subjects: 343

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 343
Study: 9237963

Group type: EXPERIMENTAL
Intervention: Olestra 32 g
Number of subjects: 68

Group type: COMPARATOR
Intervention: Olestra 0 g (placebo)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Olestra 8 g
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Olestra 20 g
Number of subjects: 68
Study: 8505632

Group type: EXPERIMENTAL
Intervention: Lamotrigine (150 mg or 300 mg daily depending on concomitant AEDs)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 41
Study: 3321875

Group type: COMPARATOR
Intervention: 0.00% oxygen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.01% oxygen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2.65% oxygen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5.13% oxygen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10.3% oxygen
Number of subjects: 10
Study: 30019170

Group type: EXPERIMENTAL
Intervention: Immediate functional loading of short implants (6 mm)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Delayed loading of short implants (6 mm)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Immediate and delayed loading of short implants (6 mm)
Number of subjects: 63
Study: 28758312

Group type: EXPERIMENTAL
Intervention: Telephone interviews (T)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Postal surveys (P)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Both assessment modes
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Groups without a switch in assessment mode
Number of subjects: 323

Group type: COMPARATOR
Intervention: Groups with a switch in assessment mode
Number of subjects: 323
Study: 25757810

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic hysterectomy
Number of subjects: 256

Group type: COMPARATOR
Intervention: Multiport laparoscopic hysterectomy
Number of subjects: 256
Study: 23380039

Group type: EXPERIMENTAL
Intervention: High intake norm (believing previous participants ate a lot of cookies)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Low intake norm (believing previous participants ate few cookies)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No norm control condition
Number of subjects: 64
Study: 21206443

Group type: EXPERIMENTAL
Intervention: Fluoxetine (up to 40 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Citalopram (up to 40 mg/d)
Number of subjects: 40
Study: 19705007

Group type: EXPERIMENTAL
Intervention: Sanitation campaign combining shaming and subsidies
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1050
Study: 17237474

Group type: EXPERIMENTAL
Intervention: Abnormal CA15-3 (>30 U/ml or >50% higher than the first value recorded)
Number of subjects: 3953

Group type: EXPERIMENTAL
Intervention: Abnormal ALP (normal, abnormal, or equivocal)
Number of subjects: 3953

Group type: EXPERIMENTAL
Intervention: Both CA15-3 and ALP abnormal
Number of subjects: 3953
Study: 15298531

Group type: EXPERIMENTAL
Intervention: Multifaceted programs for CHF management including participation of multiple health care professionals, patient and physician education, intensive drug therapy, lifestyle modifications, and close patient monitoring.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chronic outpatient management programs for hypertension and hyperlipidemia-CAD focusing on self-management skills and regular follow-up.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Case management and physician education for CHF management.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pharmacist-managed clinics and automated provider notices for hypertension and hyperlipidemia-CAD management.
Number of subjects: 20
Study: 11910298

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring (ABPM)
Number of subjects: 6083

Group type: COMPARATOR
Intervention: Clinic BP
Number of subjects: 6083
Study: 9689369

Group type: EXPERIMENTAL
Intervention: 4-week isotonic resistance training program using Theraband elastic tubing and lightweight dumbbells
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 8607111

Group type: EXPERIMENTAL
Intervention: Calciparine (5,000 IU prophylactic, 12,500 IU curative)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fraxiparine (3,075 IU prophylactic, 6,150 IU curative)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fraxiparine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Calciparine
Number of subjects: 17
Study: 2674064

Group type: EXPERIMENTAL
Intervention: Liquid-crystal-contact-thermography (LCCT)
Number of subjects: 300
Study: 31908300

Group type: EXPERIMENTAL
Intervention: Cabazitaxel plus carboplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30921176

Group type: EXPERIMENTAL
Intervention: Teaching chest compression first (Group 2)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard CPR training (Group 1)
Number of subjects: 95
Study: 28842139

Group type: EXPERIMENTAL
Intervention: High-dose daunorubicin (90 mg/m2 on days 1-3) and cytosine arabinoside (200 mg/m2/day continuous infusion on days 1-7)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-dose daunorubicin (45 to 60 mg/m2)
Number of subjects: 26
Study: 25373684

Group type: EXPERIMENTAL
Intervention: Group Teen Triple P (GTTP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: care as usual (CAU)
Number of subjects: 72
Study: 23859487

Group type: EXPERIMENTAL
Intervention: Red orange juice
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Blond orange juice
Number of subjects: 17
Study: 22586902

Group type: EXPERIMENTAL
Intervention: cycloferon suppositoria
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: intramuscular cycloferon
Number of subjects: 126

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 126
Study: 19370543

Group type: COMPARATOR
Intervention: Chlorhexidine 0.12% mouthrinse
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lippia sidoides essential oil 1% mouthrinse
Number of subjects: 55
Study: 16618855

Group type: EXPERIMENTAL
Intervention: Laser group (laser-guided collimator)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-laser group (conventional rectangular collimator)
Number of subjects: 18
Study: 15871639

Group type: EXPERIMENTAL
Intervention: Intravenous imipenem 1g plus cilastatin 1g
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous meropenem 1g
Number of subjects: 20
Study: 11684937

Group type: EXPERIMENTAL
Intervention: Consistent condom use
Number of subjects: 17264

Group type: EXPERIMENTAL
Intervention: Irregular condom use
Number of subjects: 17264
Study: 9203726

Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV2) administered after recent diarrhea history
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV1, OPV2, OPV3, OPV4)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Multivariate models controlling for various factors
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Current recommendation for children with diarrhea to receive OPV and be reimmunized post-illness
Number of subjects: 728
Study: 7963412

Group type: EXPERIMENTAL
Intervention: recombinant alpha interferon (6 MU x 3/week for 3 months then 3 MU x 3/week for 3 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: recombinant alpha interferon (3 MU x 3/week for 6 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: recombinant alpha interferon
Number of subjects: 75
Study: 3113995

Group type: EXPERIMENTAL
Intervention: Rifampicin regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-rifampicin regimen
Number of subjects: 0
Study: 31014200

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate ablation (CAA)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 400
Study: 28558104

Group type: EXPERIMENTAL
Intervention: Parent-based treatment (PBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Family-based treatment (FBT)
Number of subjects: 150
Study: 26006754

Group type: EXPERIMENTAL
Intervention: UMEC/VI 62.5/25 mcg
Number of subjects: 703

Group type: COMPARATOR
Intervention: FP/SAL 250/50 mcg
Number of subjects: 703
Study: 23480875

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maize porridge plus oil
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Maize porridge
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Water
Number of subjects: 13
Study: 21952084

Group type: EXPERIMENTAL
Intervention: Practice Outreach Facilitation with regular monthly meetings over a one- to two-year period, including audit and feedback, consensus building, and goal setting.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of Practice Outreach Facilitators' written narratives of their ongoing practice interactions.
Number of subjects: 0
Study: 19307290

Group type: EXPERIMENTAL
Intervention: Head shake modification to the Sensory Organization Test (SOT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard Sensory Organization Test (SOT)
Number of subjects: 91
Study: 16520833

Group type: EXPERIMENTAL
Intervention: Labetalol (1.2 mg/kg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 26
Study: 14995053

Group type: EXPERIMENTAL
Intervention: Flaxseed
Number of subjects: 0
Study: 11120566

Group type: EXPERIMENTAL
Intervention: Analysis of visual pigment genes in mothers of males with congenital color-vision deficiencies
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Analysis of visual pigment genes in randomly-selected females
Number of subjects: 146
Study: 9644632

Group type: EXPERIMENTAL
Intervention: Patients with osteitis fibrosa (OF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with osteomalacia (OM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with osteitis fibrosa (OF) and osteomalacia (OM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with renal osteodystrophy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Therapeutic intervention
Number of subjects: 40
Study: 7931010

Group type: EXPERIMENTAL
Intervention: 3 mg or 6 mg relaxin (rhRlx) gel
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 11
Study: 2908516

Group type: EXPERIMENTAL
Intervention: Ketazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam (challenge dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term benzodiazepine use
Number of subjects: 0
Study: 31933278

Group type: EXPERIMENTAL
Intervention: L-Fe diet (0 mg/kg Fe)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: M-Fe diet (80 mg/kg Fe)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: H-Fe diet (160 mg/kg Fe)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Mn sulfate (MnSO4)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Manganese-lysine chelate (MnLys)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control (Fe and Mn unsupplemented diets)
Number of subjects: 900
Study: 30699301

Group type: EXPERIMENTAL
Intervention: Azithromycin plus sulfadoxine‐pyrimethamine plus amodiaquine
Number of subjects: 19578

Group type: COMPARATOR
Intervention: Placebo plus sulfadoxine‐pyrimethamine plus amodiaquine
Number of subjects: 19578
Study: 28610675

Group type: EXPERIMENTAL
Intervention: Single moderate-to-severe exacerbation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-exacerbators
Number of subjects: 0
Study: 25175757

Group type: EXPERIMENTAL
Intervention: 30% red sorghum pasta (RSP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control pasta (CP)
Number of subjects: 20
Study: 23496939

Group type: EXPERIMENTAL
Intervention: Intervention group (home visits and group activities)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 459
Study: 21773032

Group type: EXPERIMENTAL
Intervention: Combination therapy (ritodrine and magnesium)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Magnesium alone
Number of subjects: 33
Study: 18242069

Group type: EXPERIMENTAL
Intervention: Lower Limb Training Group (LLTG)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Upper Limb Training Group (ULTG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 22
Study: 17070175

Group type: EXPERIMENTAL
Intervention: Policosanol 20 mg/d for 12 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d for 12 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Combination therapy (Policosanol + Atorvastatin)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 12603503

Group type: EXPERIMENTAL
Intervention: AAT deficiency subjects (n=86)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (n=27)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: AAT deficiency subjects (hyperresponsive)
Number of subjects: 114
Study: 12556657

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 9

Group type: COMPARATOR
Intervention: Antihypertensive drugs (various classes)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Untreated control patients
Number of subjects: 9
Study: 10827879

Group type: EXPERIMENTAL
Intervention: Involuntary out-patient commitment (OPC) for > or = 6 months
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Extended OPC combined with regular out-patient services, adherence to prescribed medications, and no substance misuse
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (no OPC)
Number of subjects: 262
Study: 9025797

Group type: EXPERIMENTAL
Intervention: Hypobaria (barometric pressure of 429 mmHg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normobaric environment (baseline condition)
Number of subjects: 0
Study: 1346563

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terfenadine (120 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6743447

Group type: EXPERIMENTAL
Intervention: morphine sulphate 2 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: diamorphine hydrochloride 2 mg
Number of subjects: 27
Study: 2872740

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy and aspirin therapy
Number of subjects: 500

Group type: COMPARATOR
Intervention: Aspirin therapy alone
Number of subjects: 500
Study: 31691105

Group type: EXPERIMENTAL
Intervention: aPAP + SensAwake (SA)
Number of subjects: 85

Group type: COMPARATOR
Intervention: aPAP
Number of subjects: 85
Study: 29725795

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine with epinephrine 1/200,000
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine without epinephrine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 37
Study: 28629874

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham rTMS intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Baseline (before rTMS)
Number of subjects: 12
Study: 25691293

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) combined with pegylated interferon alpha-2b (PEG-IFNα-2b)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (palliative therapy)
Number of subjects: 105
Study: 23413910

Group type: EXPERIMENTAL
Intervention: Inhaled inactivated Mycobacterium phlei
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled Seretide
Number of subjects: 0